Cancer Family
Rhabdoid Tumor
CI-CAN-00000342Explore in graph →
Non-malignant32 active trials3 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000342Explore in graph →
Clinical trials
77 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04521946 | Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 26, 2024 | clinicaltrials |
| NCT05952687 | Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors | withdrawn | Phase 1 | 0 | St. Jude Children's Research HospitalOTHER | 0 | Mar 27, 2024 | clinicaltrials |
| NCT01453465 | Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor | withdrawn | — | 0 | Children's Oncology GroupNETWORK | 1 | Aug 7, 2018 | clinicaltrials |
| NCT01642095 |
Data updated 22 days agoSource updated Oct 26, 2024source: clinicaltrials
| Studying Biomarkers in Samples From Younger Patients With Kidney Cancer |
| withdrawn |
| — |
| 0 |
| Children's Oncology GroupNETWORK |
| 1 |
| Aug 7, 2018 |
| clinicaltrials |